Innovar, Ionsys(fentanyl)
Actiq, Duragesic, Effentora, Fentora, Innovar, Instanyl, Ionsys, PecFent, Sublimaze, Subsys (fentanyl) is a small molecule pharmaceutical. Fentanyl was first approved as Innovar on 1982-01-01. It is used to treat pain in the USA. It has been approved in Europe to treat neoplasms, pain, and postoperative pain. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target kappa-type opioid receptor and delta-type opioid receptor.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Actiq, Fentora, Sublimaze (generic drugs available since 1991-09-24, discontinued: Abstral, Duragesic, Ionsys, Lazanda, Onsolis, Subsys)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Droperidol
+
Fentanyl citrate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INNOVAR | Akorn | N-016049 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Fentanyl
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SUBSYS | MMB Healthcare | N-202788 DISCN | 2012-01-04 | 7 products, RLD |
DURAGESIC-37 | Johnson & Johnson | N-019813 DISCN | 2018-01-24 | 1 products, RLD |
DURAGESIC-12 | Johnson & Johnson | N-019813 DISCN | 2005-02-04 | 1 products, RLD |
DURAGESIC-100 | Johnson & Johnson | N-019813 DISCN | 1990-08-07 | 1 products, RLD |
DURAGESIC-75 | Johnson & Johnson | N-019813 DISCN | 1990-08-07 | 1 products, RLD |
DURAGESIC-50 | Johnson & Johnson | N-019813 DISCN | 1990-08-07 | 1 products, RLD |
DURAGESIC-25 | Johnson & Johnson | N-019813 DISCN | 1990-08-07 | 1 products, RLD |
Hide discontinued
Fentanyl citrate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SUBLIMAZE PRESERVATIVE FREE | Akorn | N-016619 RX | 1982-01-01 | 1 products, RLD, RS |
ACTIQ | Cephalon | N-020747 RX | 1998-11-04 | 6 products, RLD |
FENTORA | Cephalon | N-021947 RX | 2006-09-25 | 5 products, RLD |
FENTANYL CITRATE | Exela Pharma Sciences | N-215870 RX | 2023-02-08 | 2 products, RLD, RS |
FENTANYL CITRATE | Hikma Pharmaceuticals | N-019101 RX | 1984-07-11 | 2 products, RLD, RS |
FENTANYL CITRATE | Hospira | N-019115 RX | 1985-01-12 | 1 products |
Show 5 discontinued
Fentanyl hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
IONSYS | The Medicines Company | N-021338 DISCN | 2006-05-22 | 1 products, RLD |
Hide discontinued
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pain | EFO_0003843 | D010146 | R52 |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Fentanyl Hydrochloride, Ionsys, The Medicines Co | |||
9095706 | 2033-02-03 | DP | |
8428709 | 2032-06-11 | DP | U-736 |
8428708 | 2032-05-21 | U-736 | |
8781571 | 2032-03-31 | DP | U-736 |
9731121 | 2031-10-17 | DP | |
8301238 | 2031-09-30 | DP | |
9364656 | 2031-09-30 | U-736 | |
6975902 | 2024-04-01 | DP | |
Fentanyl Citrate, Lazanda, Btcp Pharma | |||
9731869 | 2032-01-26 | DP | |
8216604 | 2024-10-03 | U-767 | |
8889176 | 2024-01-16 | U-767 | |
9078814 | 2024-01-08 | DP | |
9814705 | 2024-01-08 | DP | |
Fentanyl, Subsys, Btcp Pharma | |||
8486972 | 2030-04-27 | DP | |
8486973 | 2030-04-27 | U-55 | |
8835459 | 2027-01-25 | DP | |
8835460 | 2027-01-25 | DP | U-55 |
9241935 | 2027-01-25 | DP | |
9289387 | 2027-01-25 | DP | U-55 |
9642797 | 2027-01-25 | DP | U-55 |
9642844 | 2027-01-25 | DP | |
10016403 | 2027-01-25 | DP | |
10610523 | 2027-01-25 | DP | |
Fentanyl Citrate, Fentora, Cephalon | |||
7862832 | 2028-06-15 | DP | |
7862833 | 2028-06-15 | DP | |
8092832 | 2024-12-30 | DP | |
8119158 | 2024-12-30 | DP | |
Fentanyl Citrate, Onsolis, Adalvo | |||
9597288 | 2027-07-23 | DP | U-767 |
Clinical
Clinical Trials
822 clinical trials
View more details

Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | 8 | 13 | 33 | 33 | 28 | 112 |
Postoperative pain | D010149 | G89.18 | 6 | 8 | 7 | 35 | 28 | 81 | |
Neoplasms | D009369 | C80 | 2 | 13 | 20 | 3 | 7 | 41 | |
Anesthesia | D000758 | 3 | 2 | 4 | 11 | 17 | 36 | ||
Labor pain | D048949 | 3 | 1 | 3 | 13 | 9 | 28 | ||
Chronic pain | D059350 | HP_0012532 | 1 | 2 | 9 | 7 | 7 | 25 | |
Analgesia | D000698 | — | 1 | 8 | 4 | 9 | 21 | ||
Acute pain | D059787 | R52 | 2 | 2 | 3 | 9 | 6 | 21 | |
Cancer pain | D000072716 | G89.3 | 1 | 1 | 7 | 4 | 7 | 19 | |
Healthy volunteers/patients | — | 14 | 1 | — | 2 | 1 | 17 |
Show 138 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 1 | — | 2 | 4 |
Morbid obesity | D009767 | EFO_0001074 | — | — | 1 | — | 3 | 4 | |
Postpartum depression | D019052 | EFO_0007453 | F53.0 | — | 1 | 1 | — | 1 | 2 |
Hypospadias | D007021 | EFO_0004209 | Q54 | — | 1 | 1 | — | 1 | 2 |
Mucositis | D052016 | EFO_1001898 | — | — | 2 | — | — | 2 | |
Intractable pain | D010148 | — | 1 | 1 | — | — | 2 | ||
Traumatic brain injuries | D000070642 | S06 | — | 1 | 1 | — | — | 2 | |
Complex regional pain syndromes | D020918 | EFO_1001998 | — | — | 1 | — | 1 | 2 | |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | 1 | — | — | 1 |
Congenital cystic adenomatoid malformation of lung | D015615 | — | — | 1 | — | — | 1 |
Show 24 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Dyspnea | D004417 | HP_0002094 | R06.0 | 2 | 2 | — | — | 1 | 4 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | 1 | — | — | 2 | 3 |
Heart failure | D006333 | EFO_0003144 | I50 | 1 | 1 | — | — | 1 | 3 |
Heart rate | D006339 | EFO_0004326 | — | 1 | — | — | 1 | 2 | |
Scoliosis | D012600 | EFO_0004273 | M41 | — | 1 | — | — | — | 1 |
Referred pain | D053591 | — | 1 | — | — | — | 1 | ||
Radical mastectomy | D015409 | 1 | 1 | — | — | — | 1 | ||
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | 1 | — | — | — | 1 |
Avulsion fractures | D000071562 | 1 | 1 | — | — | — | 1 | ||
Bone fractures | D050723 | EFO_0003931 | T14.8 | — | 1 | — | — | — | 1 |
Show 13 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Laparoscopic cholecystectomy | D017081 | — | — | — | — | 3 | 3 | ||
Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | — | — | — | 2 | 2 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | — | — | 2 | 2 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 2 | 2 |
Cholecystectomy | D002763 | — | — | — | — | 2 | 2 | ||
Breast diseases | D001941 | N60-N65 | — | — | — | — | 2 | 2 | |
Pleural effusion | D010996 | J90 | — | — | — | — | 2 | 2 | |
Nociceptive pain | D059226 | — | — | — | — | 2 | 2 | ||
Female genital diseases | D005831 | EFO_0009549 | N85 | — | — | — | — | 2 | 2 |
Leukemia | D007938 | C95 | — | — | — | — | 2 | 2 |
Show 76 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | FENTANYL |
INN | fentanyl |
Description | Fentanyl is a monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid. It has a role as an opioid analgesic, a mu-opioid receptor agonist, an anaesthesia adjuvant, an intravenous anaesthetic, an adjuvant and an anaesthetic. It is a member of piperidines, an anilide and a monocarboxylic acid amide. |
Classification | Small molecule |
Drug class | Opioid |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1 |
Target
Variants
Clinical Variant
No data
Financial
Subsys - Insys Therapeutics, Inc.
$
€
£
₣

Mock data
Subscribe for the real data
Subscribe for the real data

Mock data
Subscribe for the real data
Subscribe for the real data
Lazanda - Assertio Therapeutics
$
€
£
₣

Mock data
Subscribe for the real data
Subscribe for the real data

Mock data
Subscribe for the real data
Subscribe for the real data
Actiq - Cephalon
$
€
£
₣

Mock data
Subscribe for the real data
Subscribe for the real data

Mock data
Subscribe for the real data
Subscribe for the real data
Fentora - Cephalon
$
€
£
₣

Mock data
Subscribe for the real data
Subscribe for the real data

Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 50,825 documents
View more details
Safety
Black-box Warning
Black-box warning for: Abstral, Actiq, Fentora, Lazanda, Subsys
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
8,847 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more